Theralase Technologies Inc. Logo

Theralase Technologies Inc. (TLT)

TSXV

Currency in CAD
0.1750
-0.0050 (-2.78%)

Closed

Oct 9, 2026

Day's Range

0.1750
0.1800

52 wk Range

0.1500
0.4100

Overview - TLT - Theralase Technologies Inc.

Key Statistics

Valuation

Enterprise Value

49.22M

P/E (Trailing)

‪-10.93‬

P/E (Forward)

‪-17.50‬

PEG Ratio

‪-17.50‬

Price / Sales (TTM)

‪67.70‬

Price / Book

‪7.60‬

EV / EBITDA

‪-13.48‬

Profitability

Gross Margin

‪52.07%‬

Profit Margin

‪62.11%‬

Operating Margin

‪-647.23%‬

Return on Assets

‪-42.70%‬

Return on Equity

‪-93.40%‬

Ownership

Shares Outstanding

295.67M

Float

291.32M

Held by Insiders

‪8.44%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪0.48‬

50-Day Avg

‪0.2050‬

200-Day Avg

‪0.2470‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Buy

1 analysts

News Teaser - TLT - Theralase Technologies Inc.

News & Analysis

View all news

Market Cap - TLT - Theralase Technologies Inc.

Peers - TLT - Theralase Technologies Inc.

Peer Comparison

Compared with companies in Medical Devices listed on TSXV.

Profile Summary - TLT - Theralase Technologies Inc.

About

Theralase Technologies Inc. is a prominent player in the medical technology sector, focusing on the design, manufacture, and commercialization of innovative laser technologies. The company's primary purpose is to develop advanced laser systems for therapeutic medical treatments, particularly in the fields of oncology…

SectorHealthcare
IndustryMedical Devices
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.